What are the potential benefits of Gonadorelin (GnRH)?

Restoration of physiological LH/FSH secretion in hypothalamic hypogonadism. Diagnostic test for pituitary gonadotroph reserve. Treatment of hypothalamic amenorrhea and idiopathic hypogonadotropic hypogonadism. Male infertility treatment preserving spermatogenesis (unlike GnRH agonists). Ovulation induction in anovulatory females

What compounds work synergistically with Gonadorelin (GnRH)?

Gonadorelin (GnRH) has been studied alongside Kisspeptin, hCG (for ovulation triggering), Clomiphene for potential synergistic effects.

Gonadorelin (GnRH) — Mechanism, Benefits, Research & Synergies

Overview

Gonadorelin is the synthetic form of naturally occurring gonadotropin-releasing hormone (GnRH/LHRH), a decapeptide produced by hypothalamic neurons and released in a pulsatile fashion to stimulate pituitary LH and FSH secretion. When administered in a physiologically pulsatile pattern, gonadorelin restores normal gonadotropin secretion in hypothalamic hypogonadism. Used diagnostically to assess pituitary LH/FSH reserve and therapeutically in pulsatile pump delivery for hypothalamic amenorrhea and male infertility. Continuous administration (like GnRH agonists) causes receptor downregulation.

Mechanism of Action

Gonadorelin binds GnRH receptor (GnRHR), a Gq/11-coupled GPCR on pituitary gonadotroph cells. Pulsatile GnRH activates phospholipase C, generating IP3-mediated calcium release and PKC activation, which stimulates synthesis and release of both LH and FSH. The pulsatile pattern is critical: the GnRHR requires episodic stimulation (approximately every 60-90 minutes for optimal LH/FSH release in females; every 90-180 minutes in males). Continuous exposure causes receptor internalization and downregulation—the mechanism exploited by GnRH agonists like leuprolide for medical castration.

Potential Benefits

Restoration of physiological LH/FSH secretion in hypothalamic hypogonadism
Diagnostic test for pituitary gonadotroph reserve
Treatment of hypothalamic amenorrhea and idiopathic hypogonadotropic hypogonadism
Male infertility treatment preserving spermatogenesis (unlike GnRH agonists)
Ovulation induction in anovulatory females

Research Dosage Notes

The following reflects doses used in published research studies. This is not medical advice.

Diagnostic: 100 mcg IV bolus (GnRH stimulation test). Therapeutic pulsatile pump: 25-75 ng/kg/pulse every 60-90 minutes for hypothalamic amenorrhea.

Amino Acid Sequence

pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2

Side Effects & Safety

Flushing, nausea (acute injection)
Multiple gestation risk with ovulation induction
Injection site reactions (pump therapy)
OHSS risk in ovulation induction protocols

Synergistic Compounds

The following compounds have been studied alongside Gonadorelin (GnRH) for potential complementary or synergistic effects:

KisspeptinhCG (for ovulation triggering)Clomiphene

Learn More

Beginner's GuideNew to peptides? Start here Stacking GuideSynergistic combinations Administration RoutesSubQ, IM, oral, nasal & more Reconstitution CalculatorCalculate exact dosing Peptides vs SARMsFull comparison How Peptides Are MadeSPPS, purification & QC

References & Further Reading

[object Object]
[object Object]

Quick Facts

Molecular Weight	1182.3 g/mol
Research Status	FDA-approved for diagnostic use (Factrel). Pulsatile pump therapy approved in Europe; orphan drug status for IHH in US. Pulsatile pump devices (e.g., Lutrepulse) approved historically.

More Peptides in This Category

PT-141 Melanotan II Kisspeptin Kisspeptin-10 Oxytocin Leuprolide

Gonadorelin (GnRH)